Page 157 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

207. Hadley J, Yabroff KR, Barrett MJ, et al. 217. Choo R, Long J, Gray R, et al. Prospective
Comparative effectiveness of prostate cancer
treatments: evaluating statistical adjustments
for confounding in observational data. J Natl
Cancer Inst 2010;102:1780-1793.
208. Wong YN, Mitra N, Hudes G, et al. Survival
associated with treatment vs observation of 218.
localized prostate cancer in elderly men.
JAMA 2006;296:2683-2693.
209. Albertsen PC, Hanley JA, Penson DF, et al.
13-year outcomes following treatment for 219.
clinically localized prostate cancer in a
population based cohort. J Urol
2007;177:932-936.
210. Bill-Axelson A, Holmberg L, Ruutu M, et 220.
al. Radical prostatectomy versus watchful
waiting in early prostate cancer. N Engl J
Med 2005;352:1977-1984.
211. Iversen P, Madsen PO, Corle DK. Radical
prostatectomy versus expectant treatment for
early carcinoma of the prostate. Twenty- 221.
three year follow-up of a prospective
randomized study. Scand J Urol Nephrol
Suppl 1995;172:65-72.
212. Hegarty J, Beirne PV, Walsh E, et al.
Radical prostatectomy versus watchful
waiting for prostate cancer. Cochrane 222.
Database Syst Rev 2010;CD006590.
213. Bill-Axelson A, Holmberg L, Ruutu M, et
al. Radical prostatectomy versus watchful
waiting in early prostate cancer. N Engl J 223.
Med 2011;364:1708-1717.
214. Johansson E, Bill-Axelson A, Holmberg L,
et al. Time, symptom burden, androgen
deprivation, and self-assessed quality of life
after radical prostatectomy or watchful 224.
waiting: the Randomized Scandinavian
Prostate Cancer Group Study Number 4
(SPCG-4) clinical trial. Eur Urol
2009;55:422-430.
215. Steineck G, Helgesen F, Adolfsson J, et al.
Quality of life after radical prostatectomy or
watchful waiting. N Engl J Med 225.
2002;347:790-796.
216. Fransson P, Damber JE, Tomic R, et al.
Quality of life and symptoms in a
randomized trial of radiotherapy versus
deferred treatment of localized prostate
carcinoma. Cancer 2001;92:3111-3119.
103
survey of sexual function among patients
with clinically localized prostate cancer
referred for definitive radiotherapy and the
impact of radiotherapy on sexual function.
Support Care Cancer 2010;18:715-722.
Elliott SP, Meng MV, Elkin EP, et al.
Incidence of urethral stricture after primary
treatment for prostate cancer: data From
CaPSURE. J Urol 2007;178:529-534.
Zhou EH, Ellis RJ, Cherullo E, et al.
Radiotherapy and survival in prostate cancer
patients: a population-based study. Int J
Radiat Oncol Biol Phys 2009;73:15-23.
Abdel-Wahab M, Reis IM, Hamilton K.
Second primary cancer after radiotherapy
for prostate cancer--a seer analysis of
brachytherapy versus external beam
radiotherapy. Int J Radiat Oncol Biol Phys
2008;72:58-68.
Tewari A, Divine G, Chang P, et al. Long-
term survival in men with high grade
prostate cancer: a comparison between
conservative treatment, radiation therapy
and radical prostatectomy—a propensity
scoring approach. J Urol 2007;177:911-915.
Smith DP, King MT, Egger S, et al. Quality
of life three years after diagnosis of
localised prostate cancer: population based
cohort study. BMJ 2009;339:b4817.
Stattin P, Holmberg E, Johansson JE, et al.
Outcomes in localized prostate cancer:
National Prostate Cancer Register of
Sweden follow-up study. J Natl Cancer Inst
2010;102:950-958.
Thong MS, Mols F, Kil PJ, et al. Prostate
cancer survivors who would be eligible for
active surveillance but were either treated
with radiotherapy or managed expectantly:
comparisons on long-term quality of life and
symptom burden. BJU Int 2010;105:652-
658.
Fransson P, Damber JE, Widmark A.
Health-related quality of life 10 years after
external beam radiotherapy or watchful
waiting in patients with localized prostate
cancer. Scand J Urol Nephrol 2009;43:119-
126.